Bio, I share your view about Sygenus potential.
It would be good if we could get a status report on where things are up to with:
- commercialising the acne treatment;
- the Adelaide Uni/Macquarie Uni follow up to the Israeli study findings on use of Sygenus for pain management;
- current and planned studies into use of Sygenus for other specific medical/dermatological conditions.
i can’t see that there would be a commercial need for the company to be a secret squirrel about any of those 3 things.
zeno9
Ann: New CEO Appointed to Accelerate Global Growth, page-22
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.020(4.76%) |
Mkt cap ! $4.772M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.0¢ | 40.0¢ | $2.792K | 6.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7117 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 1910 | 1 |
View Market Depth
| Last trade - 14.13pm 29/07/2024 (20 minute delay) ? |
| CMB (ASX) Chart |